In a new job - June 4, 2021
She is the new CFO at AstraZeneca
The company has appointed Aradhana Sarin as new Chief Financial Officer. Marc Dunoyer to retire from the Board and take up a new senior executive role with the company, it states in a press release. Operating roles at Alexion and advisory roles at global financial institutions The Board has appointed Aradhana Sarin as an Executive […]
Pharma Business - May 31, 2021
AstraZeneca’s Tagrisso receives EU approval
AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumor resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumors have exon 19 deletions or exon […]
COVID-19 - May 25, 2021
Vaxzevria authorized for emergency use in Japan
AstraZeneca’s COVID-19 vaccine has been granted a special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health, Labour and Welfare granted the approval based on positive Phase III efficacy and safety data from the Oxford University-led clinical […]
Pharma Business - May 3, 2021
AstraZeneca’s Farxiga receives approval in the US
Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with chronic kidney disease (CKD) at risk of progression. The approval by the Food […]
Acquisition - April 19, 2021
AstraZeneca receives US clearance of proposed acquisition of Alexion
AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals has cleared US Federal Trade Commission review. This follows the conclusion of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The announcement follows competition clearances in Canada, Brazil, Russia and other countries globally, with a full list available on astrazeneca.com. Additional global regulatory clearances are pending, including but […]
COVID-19 - April 8, 2021
Possible link between AstraZeneca’s vaccine and rare blood clots, states EMA
The European Medicines Agency’s safety committee (PRAC) has concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group, it states […]
